-
1
-
-
0035112776
-
Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection
-
Bica I, McGovern B, Dhar R, Stone D, McGowan K, Scheib R, et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001;/32:/492-7.
-
(2001)
Clin Infect Dis
, vol.32
, pp. 492-497
-
-
Bica, I.1
McGovern, B.2
Dhar, R.3
Stone, D.4
McGowan, K.5
Scheib, R.6
-
2
-
-
85062055676
-
Liver-related deaths in persons infected with the human immunodeficiency virus: The D:A:D study
-
Weber R, Sabin CA, Friis-Moller N, Reiss P, El-Sadr WM, Kirk O, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 2006;/166:/1632-41.
-
(2006)
Arch Intern Med
, vol.166
, pp. 1632-1641
-
-
Weber, R.1
Sabin, C.A.2
Friis-Moller, N.3
Reiss, P.4
El-Sadr, W.M.5
Kirk, O.6
-
3
-
-
38949125850
-
European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults
-
Rockstroh JK, Bhagani S, Benhamou Y, Bruno R, Mauss S, Peters L, et al. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults. HIV Med 2008;/9:/82-8.
-
(2008)
HIV Med
, vol.9
, pp. 82-88
-
-
Rockstroh, J.K.1
Bhagani, S.2
Benhamou, Y.3
Bruno, R.4
Mauss, S.5
Peters, L.6
-
4
-
-
34248592912
-
Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel
-
Soriano V, Puoti M, Sulkowski M, Cargnel A, Benhamou Y, Peters M, et al. Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel. AIDS 2007;/21:/1073-89.
-
(2007)
AIDS
, vol.21
, pp. 1073-1089
-
-
Soriano, V.1
Puoti, M.2
Sulkowski, M.3
Cargnel, A.4
Benhamou, Y.5
Peters, M.6
-
5
-
-
38749083392
-
Spontaneous HCV clearance in HCV/HIV-1 coinfection associated with normalized CD4 counts, low level of chronic immune activation and high level of T cell function
-
Falconer K, Gonzalez VD, Reichard O, Sandberg JK, Alaeus A. Spontaneous HCV clearance in HCV/HIV-1 coinfection associated with normalized CD4 counts, low level of chronic immune activation and high level of T cell function. J Clin Virol 2008;/41:/160-3.
-
(2008)
J Clin Virol
, vol.41
, pp. 160-163
-
-
Falconer, K.1
Gonzalez, V.D.2
Reichard, O.3
Sandberg, J.K.4
Alaeus, A.5
-
6
-
-
43249088693
-
Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir
-
Vispo E, Barreiro P, Pineda JA, Mira JA, Maida I, Martin- Carbonero L, et al. Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir. Antivir Ther 2008;/13:/429-37. (Pubitemid 352016736)
-
(2008)
Antiviral Therapy
, vol.13
, Issue.3
, pp. 429-437
-
-
Vispo, E.1
Barreiro, P.2
Pineda, J.A.3
Mira, J.A.4
Maida, I.5
Martin-Carbonero, L.6
Rodriguez-Novoa, S.7
Santos, I.8
Lopez-Cortes, L.F.9
Merino, D.10
Rivero, A.11
Soriano, V.12
-
7
-
-
33751225955
-
Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic
-
Mehta SH, Lucas GM, Mirel LB, Torbenson M, Higgins Y, Moore RD, et al. Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic. AIDS 2006;/20:/ 2361-2369
-
(2006)
AIDS
, vol.20
, pp. 2361-2369
-
-
Mehta, S.H.1
Lucas, G.M.2
Mirel, L.B.3
Torbenson, M.4
Higgins, Y.5
Moore, R.D.6
-
8
-
-
10344230440
-
Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: A randomized controlled trial
-
Carrat F, Bani-Sadr F, Pol S, Rosenthal E, Lunel-Fabiani F, Benzekri A, et al. Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA 2004;/292:/2839-48.
-
(2004)
JAMA
, vol.292
, pp. 2839-2848
-
-
Carrat, F.1
Bani-Sadr, F.2
Pol, S.3
Rosenthal, E.4
Lunel-Fabiani, F.5
Benzekri, A.6
-
9
-
-
34848813462
-
Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: The PRESCO trial
-
Nunez M, Miralles C, Berdun MA, Losada E, Aguirrebengoa K, Ocampo A, et al. Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial. AIDS Res Hum Retroviruses 2007;/23:/972-82.
-
(2007)
AIDS Res Hum Retroviruses
, vol.23
, pp. 972-982
-
-
Nunez, M.1
Miralles, C.2
Berdun, M.A.3
Losada, E.4
Aguirrebengoa, K.5
Ocampo, A.6
-
10
-
-
3343012408
-
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIVinfected patients
-
Torriani FJ, Rodriguez-Torres M, Rockstroh JK, Lissen E, Gonzalez-Garcia J, Lazzarin A, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIVinfected patients. N Engl J Med 2004;/351:/438-50.
-
(2004)
N Engl J Med
, vol.351
, pp. 438-450
-
-
Torriani, F.J.1
Rodriguez-Torres, M.2
Rockstroh, J.K.3
Lissen, E.4
Gonzalez-Garcia, J.5
Lazzarin, A.6
-
11
-
-
50649112802
-
Treatment predictors of a sustained virologic response in hepatitis B and C
-
Kau A, Vermehren J, Sarrazin C. Treatment predictors of a sustained virologic response in hepatitis B and C. J Hepatol 2008;/49:/634-51.
-
(2008)
J Hepatol
, vol.49
, pp. 634-651
-
-
Kau, A.1
Vermehren, J.2
Sarrazin, C.3
|